My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

92.77 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

59 60 Next >

Price Over Earnings Overview: AstraZeneca ↗

April 18, 2023

Via Benzinga

Why AstraZeneca Shares Are Trading Higher Today? ↗

April 18, 2023

AstraZeneca plc's (NASDAQ: AZN) vaccine head highlighted the confidence that the company's new COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants.

Via Benzinga

Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So ↗

April 18, 2023

On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.

Via Benzinga

Here's How Much $1000 Invested In AstraZeneca 5 Years Ago Would Be Worth Today ↗

April 17, 2023

Via Benzinga

AstraZeneca Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 17, 2023

Via Benzinga

Argus Research Maintains Buy Rating for AstraZeneca: Here's What You Need To Know ↗

April 13, 2023

Via Benzinga

$1000 Invested In AstraZeneca 5 Years Ago Would Be Worth This Much Today ↗

April 12, 2023

Via Benzinga

2 Top Biotech Stocks to Buy Right Now ↗

April 07, 2023

These two companies pay market-beating dividends to shareholders.

Via The Motley Fool

Check Out What Whales Are Doing With AZN ↗

April 05, 2023

Via Benzinga

A Look Into AstraZeneca Inc's Price Over Earnings ↗

March 31, 2023

Via Benzinga

Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments ↗

April 11, 2023

The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a...

Via Benzinga

Canadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assay ↗

April 10, 2023

Via Benzinga

7 Very Undervalued Penny Stocks to Buy in April 2023 ↗

April 06, 2023

Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option.

Via InvestorPlace

Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian Cancer ↗

April 05, 2023

A combination of four drugs improved outcomes in ovarian cancer treatment.

Via Investor's Business Daily

AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study ↗

April 05, 2023

Via Benzinga

A Look Into AstraZeneca's Debt ↗

March 31, 2023

Via Benzinga

AstraZeneca Unusual Options Activity ↗

March 27, 2023

Via Benzinga

2 Steady Stocks to Buy and Hold Forever ↗

March 17, 2023

Investing in these companies can help you sleep easy at night.

Via The Motley Fool

P/E Ratio Insights for AstraZeneca ↗

March 16, 2023

Via Benzinga

COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All ↗

March 31, 2023

Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many...

Via Benzinga

7 Growth Stocks That Pay Generous Dividends ↗

March 30, 2023

With these seven dividend-paying growth stocks, steady payouts plus underlying growth could produce strong long-term total returns.

Via InvestorPlace

Pieris Pharma Pushes Elarekibep Data Readout, Investors React Negatively ↗

March 29, 2023

Via Benzinga

AstraZeneca Axes Pneumonia Drug Pact With Aridis ↗

March 29, 2023

AstraZeneca plc (NASDAQ: AZN) scrapped its license agreement with Aridis Pharmaceuticals Inc (NASDAQ: ARDS).

Via Benzinga

AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review ↗

March 27, 2023

Via Benzinga

A Look Into AstraZeneca's Debt ↗

March 15, 2023

Via Benzinga

7 Blue-Chip Stocks to Buy for Capital Preservation ↗

March 23, 2023

These are the low-beta blue-chip stocks to buy as they represent companies with a strong balance sheet and healthy cash flow potential.

Via InvestorPlace

3 Exceptionally Safe Dividend Stocks That Can Turn $400,000 Into $1 Million by 2030 ↗

March 23, 2023

These historically profitable dividend-paying stocks are ideal for risk-averse investors wanting to take advantage of a bear market discount.

Via The Motley Fool

Nvidia Ramps Up Artificial Intelligence Offerings Amid AI's 'iPhone Moment' ↗

March 21, 2023

Nvidia on Tuesday demonstrated how its technology is advancing artificial intelligence in myriad industries. Nvidia stock has soared in 2023.

Via Investor's Business Daily

Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information ↗

March 21, 2023

Via Benzinga

GSK's Chief Scientist Says R&D Focus More On Infectious Disease, HIV Amid Patent Expiration, Dwindling Sales ↗

March 15, 2023

GSK Plc's (NYSE: GSK) top scientist, Tony Wood, who took the helm of R&D last August, says the R&D department is now delivering results. Wood said he is de-emphasizing R&D in oncology and that the R&D...

Via Benzinga

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

59 60 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.